Please Wait.....
Report
Europe Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
Market Report I 2023-07-03 I 130 Pages I The Insight Partners
The Europe clinical trial imaging market is expected to grow from US$ 501.22 million in 2023 to US$ 705.65 million by 2028; it is estimated to register a CAGR of 7.1% from 2023 to 2028.
Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industries Fuels Europe Clinical Trial Imaging Market
The ultimate goal of drug development is to bring new compounds with proven therapeutic effects to the market. Obtaining accurate information on conducted trials' outcomes poses a significant challenge in estimating the success rate of clinical trials, as collecting such data is expensive, time-consuming, and prone to errors. In-vivo imaging performed on human subjects in clinical trials are likely to improve the success rate of the drug development process. For example, positron emission tomography (PET) imaging can visualize radio-labeled compounds that are intended for targeted drugs in-vivo activities or monitor compound tissue exposure during clinical trial testing. Other in-vivo imaging techniques, such as magnetic resonance imaging (MRI), efficiently visualize human anatomy with the capability to visualize drug molecules in the body of clinical trial participants capable of detecting adequate sensitivity and specificity. Mass spectrometry imaging (MSI) is currently utilized to visualize drug molecules for ex-vivo tissue sections. Therefore, the increasing use of imaging techniques or modalities for clinical trial testing to determine clinical dose efficacy and toxicity leads to greater success rates of clinical trials, which, in turn, is favoring the growth of the Europe clinical trial imaging market.
Europe Clinical Trial Imaging Market Overview
The Europe clinical trial imaging market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Rise in the number of clinical trial activities for new drug development and innovative product launches by the service provider companies are a few factors likely to support the market growth in Europe during the forecast period. Further, cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established infrastructure for transport, communication, energy, and public services, along with the large patient pool and high demand for quality healthcare. Coordinating centers for clinical trials were established as part of a new funding program under the Federal Ministry of Education and Research to strengthen academic clinical research. Therefore, Germany's clinical trial approval processes are standardized, reliable, transparent, and approved for relatively short study start-up timelines. Further, in Germany, top CROs provide clinical trial imaging software for imaging studies. Pharmtrace, a Berlin-based CRO's "ERICA," provides a flexible platform for clinical trial image management combining regulatory compliance for the collection, centralization, and QC of clinical trial medical images. ERICA was developed and validated by pharmtrace intended for real-life clinical trials to document and make clinical imaging GCP-compliant correctly.
Exhibit: Europe Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Europe Clinical Trial Imaging Market Segmentation
The Europe clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.
Based on modality, the Europe clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the Europe clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the Europe clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.
Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the Europe clinical trial imaging market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Europe Market Segmentation
1.3.1 Europe Clinical Trial Imaging Market - by Modality
1.3.2 Europe Clinical Trial Imaging Market - by Offering
1.3.3 Europe Clinical Trial Imaging Market - by End User
1.3.4 Europe Clinical Trial Imaging Market - by Country
2. Europe Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Clinical Trial Imaging Market - Market Landscape
4.1 Overview
4.1.1 Europe PEST Analysis
4.2 Expert Opinion
5. Europe Clinical Trial Imaging Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. Europe Clinical Trial Imaging Market
6.1 Europe Clinical Trial Imaging Market Revenue Forecast and Analysis
7. Europe Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
7.1 Overview
7.1.1 Europe Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.2 Tomography
7.2.1 Overview
7.2.2 Tomography: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.3 Ultrasound
7.3.1 Overview
7.3.2 Ultrasound: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Positron Emission Tomography
7.4.1 Overview
7.4.2 PET: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 X-Ray
7.5.1 Overview
7.5.2 X-Ray: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Echocardiography
7.6.1 Overview
7.6.2 Echocardiography: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Magnetic Resonance Imaging
7.7.1 Overview
7.7.2 Magnetic Resonance Imaging: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
8.1 Overview
8.1.1 Europe Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.2 Trial Design Consulting Services
8.2.1 Overview
8.2.2 Trial Design Consulting Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.3 Read Analysis Services
8.3.1 Overview
8.3.2 Read Analysis Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Operational Imaging Services
8.4.1 Overview
8.4.2 Operational Imaging Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Imaging Software
8.5.1 Overview
8.5.2 Imaging Software: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biopharmaceutical Companies: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
9.3.1 Overview
9.3.2 Contract Research Organizations: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Academic and Research Institutes
9.4.1 Overview
9.4.2 Academic and Research Institutes: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis
10.1 Overview
10.1.1 Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
10.1.1.1 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.1.4 Germany: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.1.5 Germany: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 UK: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.2.4 UK: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.2.5 UK: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 France: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.3.4 France: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.3.5 France: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.4 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.4.4 Italy: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.4.5 Italy: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.5 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.5.4 Spain: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.5.5 Spain: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.6 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
11. Europe Clinical Trial Imaging Market - Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 eResearch Technology Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Calyx Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ICON PLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 VIDA Diagnostics Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 WCG Clinical Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medical Metrics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 IXICO plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 21. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Clinical Trial Imaging Market Segmentation
Figure 2. Europe Clinical Trial Imaging Market, by Country
Figure 3. Europe Clinical Trial Imaging Market Overview
Figure 4. Europe Clinical Trial Imaging Market, By Modality
Figure 5. Europe Clinical Trial Imaging Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Europe Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 9. Tomography: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Ultrasound: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. PET: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. X-Ray: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Echocardiography: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Magnetic Resonance Imaging: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 17. Trial Design Consulting Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Read Analysis Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Operational Imaging Services: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Imaging Software: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 23. Pharmaceutical and Biopharmaceutical Companies: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Contract Research Organizations: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 29. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security